Effects of forskolin on endogenous dopamine and acetylcholine release in rat neostriatal slices

1996 ◽  
Vol 19 (6) ◽  
pp. 520-528
Author(s):  
Hwa-Jung Kim
1992 ◽  
Vol 59 (4) ◽  
pp. 1555-1557 ◽  
Author(s):  
Silvana Consolo ◽  
Prisca Girotti ◽  
Giovanni Russi ◽  
Gaetano Di Chiara

1990 ◽  
Vol 523 (1) ◽  
pp. 51-56 ◽  
Author(s):  
Ernest Arenas ◽  
Jordi Alberch ◽  
Ricardo Sanchez Arroyos ◽  
Jordi Marsal

2012 ◽  
Vol 21 (1) ◽  
pp. 15-21
Author(s):  
Merete Bakke ◽  
Allan Bardow ◽  
Eigild Møller

Severe drooling is associated with discomfort and psychosocial problems and may constitute a health risk. A variety of different surgical and non-surgical treatments have been used to diminish drooling, some of them with little or uncertain effect and others more effective but irreversible or with side effects. Based on clinical evidence, injection with botulinum toxin (BTX) into the parotid and submandibular glands is a useful treatment option, because it is local, reversible, and with few side effects, although it has to be repeated. The mechanism of BTX is a local inhibition of acetylcholine release, which diminishes receptor-coupled secretion and results in a flow rate reduction of 25–50% for 2–7 months.


Sign in / Sign up

Export Citation Format

Share Document